GeoVax Labs, Inc. raises $3.0M Private Placement (United States, May 2026)
$3.0M
$3 MillionGenerated social card
Headline
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules - TradingView
About
GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on developing vaccines and immunotherapies for high-consequence infectious diseases and solid tumor cancers. The company is notable for its expedited regulatory pathway for its GEO-MVA vaccine targeting mpox and smallpox, with plans for a pivotal Phase 3 clinical trial in 2026.
Article summary
GeoVax Announces $3 Million Private Placement Financing Priced At-the-Market Under Nasdaq Rules TradingView
Investors
Related rounds
| Jul 25, 2026 | Casana | $46.0M | Series B | United States |
| Jul 24, 2026 | World Foundation | $52.5M | — | United States |
| Jul 24, 2026 | Petra Labs | $5.2M | — | United States |
| Jul 24, 2026 | Ramp | $750.0M | Series F | United States |